(Total Views: 537)
Posted On: 05/11/2020 1:22:17 PM
Post# of 153934
“He has also historically selected questions that are off-topic to the issues-at-hand, and a waste of precious Q&A time.”
Great points and recommendations in this post. Jack continues to ask questions that have already been answered during the initial discussion. I believe this is partially his fault and partially the fault of his system which allows investors to submit questions BEFORE the web conference takes place. That leads to a lot of wasted time.
The board has submitted a list of good questions in the past directly to NP for CCs, maybe we could do the same for the web conference. NP could then check off questions that have been addressed and answer those that haven’t.
Personally, I’d like an update on the second preclinical NASH study that CYDY initiated a few months ago. In NP’s words, it was the study that got a $1 billion licensing agreement for another biotech.
Great points and recommendations in this post. Jack continues to ask questions that have already been answered during the initial discussion. I believe this is partially his fault and partially the fault of his system which allows investors to submit questions BEFORE the web conference takes place. That leads to a lot of wasted time.
The board has submitted a list of good questions in the past directly to NP for CCs, maybe we could do the same for the web conference. NP could then check off questions that have been addressed and answer those that haven’t.
Personally, I’d like an update on the second preclinical NASH study that CYDY initiated a few months ago. In NP’s words, it was the study that got a $1 billion licensing agreement for another biotech.
(2)
(0)
